In this edition:

–  Dapagliflozin in acute HF
–  ARNI vs. placebo in congenital systemic right ventricular HF
–  Contemporary use and implications of β-blockers in HFMREF/HFPEF
–  Managing iron deficiency in Asian HF patients
–  β-blocker withdrawal and functional capacity improvement in HFPEF
–  Phenotyping HF by genetics and associated conditions
–  Impact of visit volume on effectiveness of electronic tools to improve HF care
–  Pharmacological treatments in HFMREF/HFPEF
–  Dementia risk with statins in HF
–  Impact of rapid up-titration of GDMT on QOL in acute HF

Download the Heart Failure Research Review: Issue 86, with commentary by Dr Mark Nolan